Cargando…
Surrogate markers and survival in women receiving first-line combination anthracycline chemotherapy for advanced breast cancer
Surrogate markers may help predict the effects of first-line treatment on survival. This metaregression analysis examines the relationship between several surrogate markers and survival in women with advanced breast cancer after receiving first-line combination anthracycline chemotherapy 5-fluoroura...
Autores principales: | Hackshaw, A, Knight, A, Barrett-Lee, P, Leonard, R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361525/ https://www.ncbi.nlm.nih.gov/pubmed/16278665 http://dx.doi.org/10.1038/sj.bjc.6602858 |
Ejemplares similares
-
Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab
por: Custodio, A, et al.
Publicado: (2017) -
Advances in anthracycline chemotherapy : epirubicin /
Publicado: (1984) -
Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy
por: Shin, Kabsoo, et al.
Publicado: (2021) -
Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy
por: Paré, L, et al.
Publicado: (2008) -
Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline/taxane-based chemotherapy
por: Campone, M, et al.
Publicado: (2006)